MARKETS
Analyst Actions

Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

Oct 7, 2026 · 12:51 PM ET· updated 22h ago

Truist Securities analyst Gregory Renza maintains MannKind (NASDAQ:MNKD) with a Buy and lowers the price target from $6 to $5.

Share
Why It Matters

An expert analyst still likes MannKind but thinks the stock might be worth less money. This means the company is still doing good things, but people should watch if the reasons for lower expectations change.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.